The global cancer gene therapy market is on the cusp of significant expansion, with sales expected to rise from USD 1,822.2 million in 2024 to a staggering USD 3,142.2 million by 2034. This impressive growth, marked by a compound annual growth rate (CAGR) of 5.6%, highlights the increasing demand for innovative cancer treatment solutions. In …